Viatris Inc
Its government footprint in one place: federal money, influence and market activity, each row linked to its source.
Government moneyⓘ
Obligations: money an agency has formally committed to pay under a contract. Not the same as money already paid, and not revenue.
ⓘ
Obligations: money an agency has formally committed to pay under a contract. Not the same as money already paid, and not revenue.Federal money for this company is being gathered from USAspending. It takes a few minutes; refresh the page later.
Contracts ending in the next 18 months
None in the contracts we hold for this company.
Amount: obligated to date. From the contracts in HillSignal's records tied to this ticker; the full list of contracts ending across government is on Recompetes.
Influence
Revolving door: 4 lobbyists on its filings held government posts
Every post as the lobbyist listed it on the company's Senate LDA filings, one per line.
- Benjamin Brownlast filed 2025 · 8 filingsBlue Ridge Law & Policy, P.C.
- Counsel, U.S. Securities and Exchange Commission
- William Walton Lileslast filed 2025 · 8 filingsBlue Ridge Law & Policy, P.C.
- Senior Counsel, U.S. House Committee on Financial Services
- Catherine Fuchslast filed 2024 · 3 filingsBlue Ridge Law & Policy, P.C.
- Policy Director, U.S. Senate Committee on Banking, Housing, and Urban Affairs
- Senior Counsel, U.S. Senate Committee on Finance
- Michael Taggartlast filed 2024 · 1 filingFerox Strategies
- Energy and Commerce Committee --Policy Director
- Rep. Cathy McMorris Rodgers -- Legislative Director
- Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director
Foreign agents (FARA)ⓘ
FARA (Foreign Agents Registration Act): people who work in the US for a foreign government, party or company must register and report what they do and what they are paid.
ⓘ
FARA (Foreign Agents Registration Act): people who work in the US for a foreign government, party or company must register and report what they do and what they are paid.Lobbying firms working for this company also represent these foreign principals. These are separate engagements: the firm's foreign work is not done for this company.
- Holland & Knightlobbied for this company to 2026
- Israel Ministry of Foreign Affairs · Israelpay not stated in the agreementfiled Jan 9, 2019
- Government of Gibraltar · Gibraltarpay not stated in the agreementfiled Sep 21, 2026
- Embassy of Japan · Japanpay not stated in the agreementfiled Sep 21, 2026
Agents registered at this firm, not necessarily assigned to this specific client: Thomas M. Reynolds, Larry D. Bucshon, Patrick Childress, Micah J. Burbanks-Ivey, Thomas M. Davis III, Robert Highsmith
Lobbying
47 filings, 2023 to 2026. Paid lobbying firms $2.1M. In-house lobbying spend $6.8M.
Firms: Blue Ridge Law & Policy, P.C., Ferox Strategies, Holland & Knight LLP, Viatris Inc., West Front Strategies LLC
Issues: Budget/Appropriations, Copyright/Patent/Trademark, Defense, Financial Institutions/Investments/Securities, Foreign Relations, Health Issues, Labor Issues/Antitrust/Workplace, Medicare/Medicaid
Contacted: House Of Representatives, Senate, Centers For Medicare And Medicaid Services (Cms), Health & Human Services, Dept Of (Hhs), Commerce, Dept Of (Doc), Securities & Exchange Commission (Sec), U.S. Trade Representative (Ustr), Natl Economic Council (Nec)
From the company's Senate LDA filings. Firm fees and in-house spend are reported on different filings, so they are shown apart. Lobbying is legal and common; it shows what the company paid to be heard on, not what it got.
PAC giving
- Ron Wyden Senate, OR$10K
- Kim Schrier House, WA$10K
- Thom Tillis Senate, NC$10K
- Gerald E. Connolly House, VA$6K
- John Curtis House, UT$6K
- Neal Patrick MD, Facs Dunn House, FL$6K
- Adam Kinzinger House, IL$5K
- John Hoeven Senate, ND$5K
The company's own PAC (linked by the connected organization on its FEC Form 1). Top candidates it gave to, all cycles we hold, from the candidates' own FEC reports; tracked candidates only, so not a complete total.
Marketⓘ
A 10b5-1 plan is a trading schedule an insider sets up in advance, so sales under it say less about the insider’s view.
ⓘ
A 10b5-1 plan is a trading schedule an insider sets up in advance, so sales under it say less about the insider’s view.Insider trades
- Campbell Paul See RemarksSold $810K · Jun 25, 2026
- Campbell Paul See RemarksSold $284K · Mar 23, 2026
Open-market buys and sells from SEC Form 4 filings; grants and option exercises left out, and trades whose filed price failed our market check. A 10b5-1 plan is a trading schedule set in advance, so those sells say little about the insider's view. The plan box is on filings from April 2023 on.
Members of Congress who traded it
- Gilbert Cisneros D-CABought $1,001 - $15,000filed 2025-12-15
- John Fetterman PASold $1,001 - $15,000filed 2025-05-15
- Rob Bresnahan R-PASold $1,001 - $15,000filed 2025-05-08
- Gilbert Cisneros D-CASold $1,001 - $15,000filed 2025-04-07
- Rohit Khanna D-CABought $1,001 - $15,000filed 2024-12-05
- Ro Khanna CASold $1,001 - $15,000filed 2024-02-05
- Ro Khanna CASold $1,001 - $15,000filed 2023-06-12
- Daniel Goldman D-NYSold $1,001 - $15,000filed 2023-05-19
Fund holders with contract wins (13F)ⓘ
13F: a quarterly SEC filing in which large investment managers list the US stocks they hold, filed up to 45 days after the quarter.
ⓘ
13F: a quarterly SEC filing in which large investment managers list the US stocks they hold, filed up to 45 days after the quarter.None found.
People and connections
Key people
- Enrietti AndrewSee Remarks
- Campbell PaulSee Remarks
- HIGGINS MELINA EDirector
- Le Goff CorinneChief Commercial Officer
- Mistras TheodoraChief Financial Officer
- Smith Scott AndrewChief Executive Officer
- KILTS JAMES MDirector
- MARK RICHARD ADirector
- Groothuis Leo FransDirector
- Maletta Matthew JosephChief Legal Officer
- Lyons Dillon JoEllenDirector
- SEVERINO MICHAELDirector
Connections
Connections to other companies, executives and members of Congress, from disclosed trades, shared officers and public filings, are part of Pro. See Pro
Activity
Every record that names this company by ticker, newest first: awards, bills, executive actions, SEC filings, news, private raises and patents.
- NewsCould an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?Oct 8, 2026
- NewsWhy Is Viatris (VTRS) Expanding Its Non Opioid Pain Portfolio Now?Oct 8, 2026
- NewsViatris Agrees to Acquire Pacira BioSciences in $1.65 Billion DealOct 8, 2026
- NewsViatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?Aug 13, 2026
- NewsViatris (VTRS) Q2 2026 Earnings Call TranscriptAug 13, 2026
- News3 Healthcare Stocks We Keep Off Our RadarJul 24, 2026
- NewsViatris Receives EMA CHMP Recommendation For Approval Of Ruxolitinib Viatris For The Treatment Of Myelofibrosis, Polycythaemia Vera And Graft-Vs-Host DiseaseJul 24, 2026
- NewsTrump Proposes 200% Generic Drug Tariffs, Sandoz Shares Drop 4.2%Jul 22, 2026
- BillTo amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.Mar 27, 2026
- BillSkinny Labels, Big Savings ActDec 5, 2025
- BillBiosimilar Red Tape Elimination ActSep 19, 2025
- BillPrEP and PEP are Prevention ActSep 4, 2025
- BillSkinny Labels, Big Savings ActJan 9, 2025
Sources and limits
USAspending (prime contracts only; no subcontracts or classified work; defense contracts can arrive up to 90 days after signing), SEC EDGAR, Senate LDA, FEC, House and Senate disclosures, the Federal Register and the White House. Companies are tied to records by exact name, a verified alias or a subsidiary in the company's own Exhibit 21; a miss is better than a wrong link. A shared date is not proof of cause, and nothing here is investment advice.